Bank of New York Mellon Corp - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$8,939,000
+1.1%
798,073
-0.7%
0.00%0.0%
Q2 2017$8,838,000
+9.0%
803,384
-2.9%
0.00%0.0%
Q1 2017$8,105,000
-6.5%
827,039
+3.1%
0.00%0.0%
Q4 2016$8,666,000
+14.0%
802,456
+8.2%
0.00%0.0%
Q3 2016$7,600,000
-2.6%
741,465
+24.1%
0.00%0.0%
Q2 2016$7,804,000
+150.1%
597,540
+110.7%
0.00%
+100.0%
Q1 2016$3,120,000
+15.4%
283,652
-3.5%
0.00%0.0%
Q4 2015$2,704,000
+26.1%
293,859
-4.9%
0.00%0.0%
Q3 2015$2,145,000
-41.7%
309,074
-17.5%
0.00%0.0%
Q2 2015$3,677,000
+23.0%
374,455
+11.0%
0.00%0.0%
Q1 2015$2,990,000
+5.1%
337,485
+3.9%
0.00%0.0%
Q4 2014$2,846,000
+26.9%
324,817
-0.2%
0.00%0.0%
Q3 2014$2,243,000
-37.7%
325,500
-52.4%
0.00%
Q2 2014$3,598,000
+127.0%
683,892
+96.4%
0.00%
Q1 2014$1,585,000
-12.4%
348,238
-3.0%
0.00%
-100.0%
Q4 2013$1,810,000
-50.1%
359,087
-49.8%
0.00%0.0%
Q3 2013$3,630,000
+104.3%
715,902
+99.8%
0.00%0.0%
Q2 2013$1,777,000358,3550.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders